NIH ACTIV working group weighs human challenge studies for SARS-CoV-2 vaccine development
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health’s Accelerating COVID-19 Therapeutic
Read moreIn a Perspective for the New England Journal of Medicine, members of the National Institutes of Health’s Accelerating COVID-19 Therapeutic
Read more